Stay updated on SafetyEfficacy Patients 4+ Brain Metastases Melanoma Clinical Trial

Sign up to get notified when there's something new on the SafetyEfficacy Patients 4+ Brain Metastases Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the SafetyEfficacy Patients 4+ Brain Metastases Melanoma Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    The site footer’s revision label changes from v3.7.1 to v3.7.2.
    Difference
    0.2%
    Check dated 2026-10-17T19:48:42.000Z thumbnail image
  2. Check
    11 days ago
    Change Detected
    Summary
    The site revision indicator in the footer changed from v3.7.0 to v3.7.1 on the access-denied page.
    Difference
    0.2%
    Check dated 2026-10-10T20:12:20.000Z thumbnail image
  3. Check
    18 days ago
    No Change Detected
  4. Check
    32 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error indicating restricted access to the study record content. The additions include a 403 header and basic site chrome (such as Home and a revision notice), replacing the usual study details.
    Difference
    18%
    Check dated 2026-09-19T20:53:53.000Z thumbnail image
  5. Check
    53 days ago
    Change Detected
    Summary
    The page revision label was updated from v3.6.5 to v3.6.6, representing a small, behind-the-scenes update to the page. There are no changes to the study details or visible content.
    Difference
    0.1%
    Check dated 2026-08-29T19:04:02.000Z thumbnail image
  6. Check
    74 days ago
    Change Detected
    Summary
    The page revision label was updated from v3.6.4 to v3.6.5 to reflect a new build of the page. The visible study content remains the same.
    Difference
    0.1%
    Check dated 2026-08-08T22:33:05.000Z thumbnail image
  7. Check
    88 days ago
    Change Detected
    Summary
    The revision label on the page was updated from v3.6.3 to v3.6.4, indicating a minor update to the page's version. No changes to trial data, eligibility criteria, or outcomes were introduced.
    Difference
    0.1%
    Check dated 2026-07-25T12:49:58.000Z thumbnail image

Stay in the know with updates to SafetyEfficacy Patients 4+ Brain Metastases Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the SafetyEfficacy Patients 4+ Brain Metastases Melanoma Clinical Trial page.